S1C5:Ethics, Patents, Repurposing, Generics

原文始发于微信公众号(化学音乐文化):S1C5:Ethics, Patents, Repurposing, Generics

S1C5:Ethics, Patents, Repurposing, Generics

JanFourman,PhD, EdD,MBA, MSRA

S1C5:Ethics, Patents, Repurposing, Generics

Eli Lilly – Pharma registration for diabetes/endocrine, women/men’s health, neural science, oncology, bone/muscle/joint therapeutic areas – 5 years
Eli Lilly – Pharmacovigilance – 7 years
Eli Lilly – Regulatory Intelligence – 3 Years
Purdue University and Roche Diagnostics – Teaching global pharma development, Africa and US
Consultant for Indiana Technical Assistance Program
Invited conference speaker
Published author

S1C5:Ethics, Patents, Repurposing, Generics
S1C5:Ethics, Patents, Repurposing, Generics

扫描左侧二维码,获取视频课;扫描右侧二维码,获取音频课

Ethics, Patents, Repurposing, Generics

Ethics:

Research Ethics in the 1900s

Current Ethics in Real Life

Patents:

Definitions

Introduction Case Study

Hatch-Waxman

Patent Term Extension (PTE)

Orange Book Patent Listing

Non-patent Statutory Exclusivity

发布者:药时代,转载请首先联系contact@drugtimes.cn获得授权

(0)
打赏 为好文打赏 支持药时代 共创新未来! 为好文打赏 支持药时代 共创新未来!
上一篇 2020年2月18日 00:00
下一篇 2020年2月18日 12:25

相关推荐

分享本页
返回顶部
「药时代创新药BD高阶研讨会」将于2023年1月7-8日在上海举办,点击这里了解详情并报名~